To include your compound in the COVID-19 Resource Center, submit it here.

Epix, Schering contrast agent deal

Epix Medical (EPIX) and Schering (FSE:SCH; SHR) partnered to develop targeted contrast agents for use in

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE